$GHDX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENOMIC HEALTH INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GENOMIC HEALTH INC. Get notifications about new insider transactions in GENOMIC HEALTH INC for free.
Page: < prev 1 ... 15 16 17 18 19 20 21 22 23 ... 28 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 16 2012 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Buy | M | 9.39 | 3,000 | 28,170 | 20,355 | 17.4 K to 20.4 K (+17.29 %) |
Oct 15 2012 | GHDX | GENOMIC HEALTH INC | HIBBS KATHY L | SVP & General Couns ... | Option Exercise | M | 21.07 | 1,250 | 26,338 | 37,750 | |
Oct 15 2012 | GHDX | GENOMIC HEALTH INC | HIBBS KATHY L | SVP & General Couns ... | Sell | S | 33.78 | 1,250 | 42,224 | 11,367 | 12.6 K to 11.4 K (-9.91 %) |
Oct 15 2012 | GHDX | GENOMIC HEALTH INC | HIBBS KATHY L | SVP & General Couns ... | Buy | M | 21.07 | 1,250 | 26,338 | 12,617 | 11.4 K to 12.6 K (+11.00 %) |
Oct 03 2012 | GHDX | GENOMIC HEALTH INC | MYERS WOODROW A JR | Director | Grant | A | 35.89 | 288 | 10,336 | 2,524 | 2.2 K to 2.5 K (+12.88 %) |
Oct 11 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 1.33 | 2,500 | 3,325 | 32,868 | |
Oct 11 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 34.80 | 2,500 | 86,990 | 14,085 | 16.6 K to 14.1 K (-15.07 %) |
Oct 11 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 1.33 | 2,500 | 3,325 | 16,585 | 14.1 K to 16.6 K (+17.75 %) |
Oct 03 2012 | GHDX | GENOMIC HEALTH INC | GRAHAM GINGER L | Director | Grant | A | 35.89 | 288 | 10,336 | 2,524 | 2.2 K to 2.5 K (+12.88 %) |
Oct 03 2012 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 35.89 | 288 | 10,336 | 59,590 | 59.3 K to 59.6 K (+0.49 %) |
Oct 03 2012 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Grant | A | 35.89 | 288 | 10,336 | 2,524 | 2.2 K to 2.5 K (+12.88 %) |
Oct 03 2012 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Grant | A | 35.89 | 288 | 10,336 | 288 | 0 to 288 |
Sep 10 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 1.33 | 2,500 | 3,325 | 35,368 | |
Sep 10 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 35.01 | 2,500 | 87,514 | 14,085 | 16.6 K to 14.1 K (-15.07 %) |
Sep 10 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 1.33 | 2,500 | 3,325 | 16,585 | 14.1 K to 16.6 K (+17.75 %) |
Sep 19 2012 | GHDX | GENOMIC HEALTH INC | Shak Steven | EVP of R&D & CMO | Sell | S | 33.76 | 5,000 | 168,800 | 348,768 | 353.8 K to 348.8 K (-1.41 %) |
Sep 17 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 31.69 | 5,000 | 158,450 | 223,406 | 228.4 K to 223.4 K (-2.19 %) |
Aug 31 2012 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | M | 10.73 | 8,250 | 88,523 | 0 | |
Aug 31 2012 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Buy | M | 10.73 | 8,250 | 88,523 | 59,302 | 51.1 K to 59.3 K (+16.16 %) |
Aug 22 2012 | GHDX | GENOMIC HEALTH INC | MYERS WOODROW A JR | Director | Option Exercise | M | 9.95 | 10,993 | 109,380 | 0 | |
Aug 22 2012 | GHDX | GENOMIC HEALTH INC | MYERS WOODROW A JR | Director | Option Exercise | M | 9.95 | 5,507 | 54,795 | 10,993 | |
Aug 22 2012 | GHDX | GENOMIC HEALTH INC | MYERS WOODROW A JR | Director | Sell | S | 35.28 | 10,993 | 387,803 | 2,236 | 13.2 K to 2.2 K (-83.10 %) |
Aug 22 2012 | GHDX | GENOMIC HEALTH INC | MYERS WOODROW A JR | Director | Buy | M | 9.95 | 10,993 | 109,380 | 13,229 | 2.2 K to 13.2 K (+491.64 %) |
Aug 22 2012 | GHDX | GENOMIC HEALTH INC | MYERS WOODROW A JR | Director | Sell | S | 35.06 | 5,507 | 193,061 | 2,236 | 7.7 K to 2.2 K (-71.12 %) |
Aug 22 2012 | GHDX | GENOMIC HEALTH INC | MYERS WOODROW A JR | Director | Buy | M | 9.95 | 5,507 | 54,795 | 7,743 | 2.2 K to 7.7 K (+246.29 %) |
Aug 22 2012 | GHDX | GENOMIC HEALTH INC | Shak Steven | EVP of R&D & CMO | Sell | S | 34.99 | 5,000 | 174,940 | 353,768 | 358.8 K to 353.8 K (-1.39 %) |
Aug 15 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 23.31 | 3,103 | 72,331 | 17,900 | |
Aug 15 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 23.31 | 1,897 | 44,219 | 21,003 | |
Aug 15 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 34.39 | 5,000 | 171,936 | 228,406 | 233.4 K to 228.4 K (-2.14 %) |
Aug 15 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 35.07 | 3,103 | 108,814 | 19,523 | 22.6 K to 19.5 K (-13.71 %) |
Aug 15 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Buy | M | 23.31 | 3,103 | 72,331 | 22,626 | 19.5 K to 22.6 K (+15.89 %) |
Aug 15 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 35.01 | 1,897 | 66,412 | 19,523 | 21.4 K to 19.5 K (-8.86 %) |
Aug 15 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Buy | M | 23.31 | 1,897 | 44,219 | 21,420 | 19.5 K to 21.4 K (+9.72 %) |
Aug 09 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 1.33 | 2,500 | 3,325 | 37,868 | |
Aug 09 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 30.49 | 2,500 | 76,236 | 14,085 | 16.6 K to 14.1 K (-15.07 %) |
Aug 09 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 1.33 | 2,500 | 3,325 | 16,585 | 14.1 K to 16.6 K (+17.75 %) |
Jul 30 2012 | GHDX | GENOMIC HEALTH INC | BAKER FELIX | Director | Option Exercise | A | 34.92 | 16,500 | 576,180 | 16,500 | |
Jul 27 2012 | GHDX | GENOMIC HEALTH INC | LIVINGSTON RANDALL S | Director | Option Exercise | M | 1.33 | 2,000 | 2,653 | 5,346 | |
Jul 27 2012 | GHDX | GENOMIC HEALTH INC | LIVINGSTON RANDALL S | Director | Sell | S | 35.90 | 2,000 | 71,800 | 6,149 | 8.1 K to 6.1 K (-24.54 %) |
Jul 27 2012 | GHDX | GENOMIC HEALTH INC | LIVINGSTON RANDALL S | Director | Buy | M | 1.33 | 2,000 | 2,653 | 8,149 | 6.1 K to 8.1 K (+32.53 %) |
Jul 25 2012 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Sell | S | 34.24 | 5,000 | 171,196 | 358,768 | 363.8 K to 358.8 K (-1.37 %) |
Jul 12 2012 | GHDX | GENOMIC HEALTH INC | Scott Randal W | CEO, InVitae Corpor ... | Sell | S | 35.52 | 300 | 10,655 | 1,185,117 | 1.2 M to 1.2 M (-0.03 %) |
Jul 12 2012 | GHDX | GENOMIC HEALTH INC | Scott Randal W | CEO, InVitae Corpor ... | Sell | S | 34.79 | 14,700 | 511,479 | 1,185,417 | 1.2 M to 1.2 M (-1.22 %) |
Jul 12 2012 | GHDX | GENOMIC HEALTH INC | Scott Randal W | CEO, InVitae Corpor ... | Sell | S | 36.65 | 200 | 7,330 | 1,200,117 | 1.2 M to 1.2 M (-0.02 %) |
Jul 12 2012 | GHDX | GENOMIC HEALTH INC | Scott Randal W | CEO, InVitae Corpor ... | Sell | S | 35.96 | 14,800 | 532,207 | 1,200,317 | 1.2 M to 1.2 M (-1.22 %) |
Jul 17 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 23.31 | 2,100 | 48,951 | 22,900 | |
Jul 17 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 35.03 | 2,100 | 73,570 | 19,523 | 21.6 K to 19.5 K (-9.71 %) |
Jul 17 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Buy | M | 23.31 | 2,100 | 48,951 | 21,623 | 19.5 K to 21.6 K (+10.76 %) |
Jul 17 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 34.64 | 5,000 | 173,207 | 233,406 | 238.4 K to 233.4 K (-2.10 %) |
Jul 06 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 1.33 | 2,500 | 3,325 | 40,368 | |
Jul 06 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 35.95 | 2,500 | 89,864 | 14,085 | 16.6 K to 14.1 K (-15.07 %) |
Jul 06 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 1.33 | 2,500 | 3,325 | 16,585 | 14.1 K to 16.6 K (+17.75 %) |
Jul 03 2012 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Grant | A | 33.40 | 299 | 9,987 | 2,236 | 1.9 K to 2.2 K (+15.44 %) |
Jul 03 2012 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 33.40 | 299 | 9,987 | 51,052 | 50.8 K to 51.1 K (+0.59 %) |
Jul 03 2012 | GHDX | GENOMIC HEALTH INC | GRAHAM GINGER L | Director | Grant | A | 33.40 | 299 | 9,987 | 2,236 | 1.9 K to 2.2 K (+15.44 %) |
Jul 03 2012 | GHDX | GENOMIC HEALTH INC | MYERS WOODROW A JR | Director | Grant | A | 33.40 | 299 | 9,987 | 2,236 | 1.9 K to 2.2 K (+15.44 %) |
Jun 27 2012 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Sell | S | 33.25 | 5,000 | 166,252 | 363,768 | 368.8 K to 363.8 K (-1.36 %) |
Jun 15 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 33.36 | 5,000 | 166,806 | 238,406 | 243.4 K to 238.4 K (-2.05 %) |
Jun 15 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Gift | G | 0.00 | 750 | 0 | 243,406 | 244.2 K to 243.4 K (-0.31 %) |
Jun 15 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Gift | G | 0.00 | 750 | 0 | 244,156 | 244.9 K to 244.2 K (-0.31 %) |
Jun 15 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Gift | G | 0.00 | 750 | 0 | 244,906 | 245.7 K to 244.9 K (-0.31 %) |
Jun 15 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Buy | P | 23.11 | 919 | 21,239 | 19,523 | 18.6 K to 19.5 K (+4.94 %) |
Jun 13 2012 | GHDX | GENOMIC HEALTH INC | Scott Randal W | CEO, InVitae Corpor ... | Sell | S | 33.31 | 15,000 | 499,655 | 1,215,117 | 1.2 M to 1.2 M (-1.22 %) |
Jun 13 2012 | GHDX | GENOMIC HEALTH INC | Scott Randal W | CEO, InVitae Corpor ... | Sell | S | 34.56 | 600 | 20,736 | 1,230,117 | 1.2 M to 1.2 M (-0.05 %) |
Jun 13 2012 | GHDX | GENOMIC HEALTH INC | Scott Randal W | CEO, InVitae Corpor ... | Sell | S | 33.74 | 14,400 | 485,826 | 1,230,717 | 1.2 M to 1.2 M (-1.16 %) |
Jun 12 2012 | GHDX | GENOMIC HEALTH INC | MYERS WOODROW A JR | Director | Option Exercise | A | 34.44 | 8,250 | 284,130 | 8,250 | |
Jun 12 2012 | GHDX | GENOMIC HEALTH INC | LIVINGSTON RANDALL S | Director | Option Exercise | A | 34.44 | 8,250 | 284,130 | 8,250 | |
Jun 12 2012 | GHDX | GENOMIC HEALTH INC | GRAHAM GINGER L | Director | Option Exercise | A | 34.44 | 8,250 | 284,130 | 8,250 | |
Jun 12 2012 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Option Exercise | A | 34.44 | 8,250 | 284,130 | 8,250 | |
Jun 12 2012 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Option Exercise | A | 34.44 | 8,250 | 284,130 | 8,250 | |
Jun 12 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Option Exercise | A | 34.44 | 8,250 | 284,130 | 8,250 | |
Jun 08 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 1.33 | 2,500 | 3,325 | 42,868 | |
Jun 08 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 33.97 | 2,500 | 84,919 | 13,507 | 16 K to 13.5 K (-15.62 %) |
Jun 08 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 1.33 | 2,500 | 3,325 | 16,007 | 13.5 K to 16 K (+18.51 %) |
May 29 2012 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Sell | S | 33.80 | 5,000 | 168,980 | 367,849 | 372.8 K to 367.8 K (-1.34 %) |
May 23 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 32.94 | 380 | 12,518 | 247,063 | 246.7 K to 247.1 K (+0.15 %) |
May 23 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 32.94 | 17,026 | 560,882 | 9,086,690 | 9.1 M to 9.1 M (+0.19 %) |
May 23 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 32.21 | 2,732 | 87,992 | 246,683 | 244 K to 246.7 K (+1.12 %) |
May 23 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 32.04 | 546 | 17,493 | 243,951 | 243.4 K to 244 K (+0.22 %) |
May 23 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 32.21 | 122,268 | 3,938,008 | 9,069,664 | 8.9 M to 9.1 M (+1.37 %) |
May 23 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 32.04 | 24,454 | 783,479 | 8,947,396 | 8.9 M to 8.9 M (+0.27 %) |
May 18 2012 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Sell | S | 32.13 | 6,137 | 197,168 | 20,202 | 26.3 K to 20.2 K (-23.30 %) |
May 18 2012 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Sell | S | 32.13 | 3,163 | 101,620 | 10,414 | 13.6 K to 10.4 K (-23.30 %) |
May 18 2012 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Sell | S | 33.52 | 11,213 | 375,888 | 26,339 | 37.6 K to 26.3 K (-29.86 %) |
May 18 2012 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Sell | S | 33.52 | 5,781 | 193,794 | 13,577 | 19.4 K to 13.6 K (-29.86 %) |
May 18 2012 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Buy | J | 0.00 | 9,134 | 0 | 26,891 | 17.8 K to 26.9 K (+51.44 %) |
May 18 2012 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Buy | J | 0.00 | 4,496 | 0 | 13,222 | 8.7 K to 13.2 K (+51.52 %) |
May 18 2012 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Sell | J | 0.00 | 9,628 | 0 | 11,210 | 20.8 K to 11.2 K (-46.20 %) |
May 18 2012 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Sell | J | 0.00 | 500,000 | 0 | 582,174 | 1.1 M to 582.2 K (-46.20 %) |
May 17 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 23.31 | 5,000 | 116,550 | 25,000 | |
May 17 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 35.00 | 5,000 | 175,000 | 245,656 | 250.7 K to 245.7 K (-1.99 %) |
May 17 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Buy | M | 23.31 | 5,000 | 116,550 | 250,656 | 245.7 K to 250.7 K (+2.04 %) |
May 17 2012 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 33.46 | 5,000 | 167,292 | 245,656 | 250.7 K to 245.7 K (-1.99 %) |
May 17 2012 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 33.69 | 1,000 | 33,686 | 17,355 | 18.4 K to 17.4 K (-5.45 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 34.46 | 517 | 17,815 | 243,405 | 242.9 K to 243.4 K (+0.21 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 34.46 | 23,104 | 796,111 | 8,922,942 | 8.9 M to 8.9 M (+0.26 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 34.25 | 1,972 | 67,541 | 242,888 | 240.9 K to 242.9 K (+0.82 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 33.11 | 540 | 17,882 | 240,916 | 240.4 K to 240.9 K (+0.22 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 34.47 | 555 | 19,129 | 240,376 | 239.8 K to 240.4 K (+0.23 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 34.25 | 88,028 | 3,014,959 | 8,899,838 | 8.8 M to 8.9 M (+1.00 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 33.11 | 24,136 | 799,237 | 8,811,810 | 8.8 M to 8.8 M (+0.27 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 34.47 | 24,769 | 853,726 | 8,787,674 | 8.8 M to 8.8 M (+0.28 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 33.92 | 3,212 | 108,951 | 239,821 | 236.6 K to 239.8 K (+1.36 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 33.67 | 897 | 30,198 | 236,609 | 235.7 K to 236.6 K (+0.38 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 32.59 | 370 | 12,058 | 235,712 | 235.3 K to 235.7 K (+0.16 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 31.53 | 175 | 5,517 | 235,342 | 235.2 K to 235.3 K (+0.07 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 33.92 | 143,388 | 4,863,721 | 8,762,905 | 8.6 M to 8.8 M (+1.66 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 33.67 | 40,073 | 1,349,070 | 8,619,517 | 8.6 M to 8.6 M (+0.47 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 32.59 | 16,526 | 538,558 | 8,579,444 | 8.6 M to 8.6 M (+0.19 %) |
May 16 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 31.53 | 7,797 | 245,824 | 8,562,918 | 8.6 M to 8.6 M (+0.09 %) |
May 14 2012 | GHDX | GENOMIC HEALTH INC | Scott Randal W | CEO, InVitae Corpor ... | Sell | S | 31.39 | 2,180 | 68,428 | 1,245,117 | 1.2 M to 1.2 M (-0.17 %) |
May 14 2012 | GHDX | GENOMIC HEALTH INC | Scott Randal W | CEO, InVitae Corpor ... | Sell | S | 30.85 | 5,620 | 173,349 | 1,247,297 | 1.3 M to 1.2 M (-0.45 %) |
May 14 2012 | GHDX | GENOMIC HEALTH INC | Scott Randal W | CEO, InVitae Corpor ... | Sell | S | 30.00 | 7,200 | 215,965 | 1,252,917 | 1.3 M to 1.3 M (-0.57 %) |
May 14 2012 | GHDX | GENOMIC HEALTH INC | Scott Randal W | CEO, InVitae Corpor ... | Sell | S | 30.29 | 400 | 12,114 | 1,260,117 | 1.3 M to 1.3 M (-0.03 %) |
May 14 2012 | GHDX | GENOMIC HEALTH INC | Scott Randal W | CEO, InVitae Corpor ... | Sell | S | 29.92 | 14,600 | 436,867 | 1,260,517 | 1.3 M to 1.3 M (-1.14 %) |
May 11 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 1.33 | 2,500 | 3,325 | 45,368 | |
May 11 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 28.87 | 2,500 | 72,174 | 13,507 | 16 K to 13.5 K (-15.62 %) |
May 11 2012 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 1.33 | 2,500 | 3,325 | 16,007 | 13.5 K to 16 K (+18.51 %) |
May 11 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 30.22 | 627 | 18,946 | 235,167 | 234.5 K to 235.2 K (+0.27 %) |
May 11 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 30.22 | 26,033 | 786,621 | 8,555,121 | 8.5 M to 8.6 M (+0.31 %) |
May 11 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 29.98 | 214 | 6,415 | 234,540 | 234.3 K to 234.5 K (+0.09 %) |
May 11 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 29.98 | 8,867 | 265,807 | 8,529,088 | 8.5 M to 8.5 M (+0.10 %) |
May 11 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 29.86 | 1,402 | 41,861 | 234,326 | 232.9 K to 234.3 K (+0.60 %) |
May 11 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 29.86 | 58,198 | 1,737,699 | 8,520,221 | 8.5 M to 8.5 M (+0.69 %) |
May 11 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 29.90 | 460 | 13,752 | 232,924 | 232.5 K to 232.9 K (+0.20 %) |
May 11 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 29.90 | 19,087 | 570,615 | 8,462,023 | 8.4 M to 8.5 M (+0.23 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.50 | 116 | 3,306 | 232,464 | 232.3 K to 232.5 K (+0.05 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.90 | 1,737 | 50,196 | 232,348 | 230.6 K to 232.3 K (+0.75 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.41 | 172 | 4,886 | 230,611 | 230.4 K to 230.6 K (+0.07 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.50 | 4,811 | 137,101 | 8,442,936 | 8.4 M to 8.4 M (+0.06 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.90 | 72,073 | 2,082,773 | 8,438,125 | 8.4 M to 8.4 M (+0.86 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.41 | 7,124 | 202,358 | 8,366,052 | 8.4 M to 8.4 M (+0.09 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.28 | 536 | 15,159 | 230,439 | 229.9 K to 230.4 K (+0.23 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.25 | 754 | 21,300 | 229,903 | 229.1 K to 229.9 K (+0.33 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.28 | 22,241 | 629,011 | 8,358,928 | 8.3 M to 8.4 M (+0.27 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.25 | 31,273 | 883,431 | 8,336,687 | 8.3 M to 8.3 M (+0.38 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.28 | 722 | 20,419 | 1,488,539 | 1.5 M to 1.5 M (+0.05 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.25 | 1,014 | 28,644 | 1,487,817 | 1.5 M to 1.5 M (+0.07 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.00 | 5 | 140 | 229,149 | 229.1 K to 229.1 K (0.00 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 27.99 | 369 | 10,330 | 229,144 | 228.8 K to 229.1 K (+0.16 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.03 | 935 | 26,208 | 228,775 | 227.8 K to 228.8 K (+0.41 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.00 | 188 | 5,264 | 8,305,414 | 8.3 M to 8.3 M (0.00 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 27.99 | 14,078 | 394,112 | 8,305,226 | 8.3 M to 8.3 M (+0.17 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.03 | 35,727 | 1,001,424 | 8,291,148 | 8.3 M to 8.3 M (+0.43 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.00 | 7 | 196 | 1,486,803 | 1.5 M to 1.5 M (0.00 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 27.99 | 514 | 14,389 | 1,486,796 | 1.5 M to 1.5 M (+0.03 %) |
May 08 2012 | GHDX | GENOMIC HEALTH INC | BAKER JULIAN | Director | Buy | P | 28.03 | 1,305 | 36,579 | 1,486,282 | 1.5 M to 1.5 M (+0.09 %) |
Apr 27 2012 | GHDX | GENOMIC HEALTH INC | LIVINGSTON RANDALL S | Director | Option Exercise | M | 1.33 | 2,000 | 2,653 | 7,346 | |
Apr 27 2012 | GHDX | GENOMIC HEALTH INC | LIVINGSTON RANDALL S | Director | Sell | S | 28.21 | 2,000 | 56,429 | 6,149 | 8.1 K to 6.1 K (-24.54 %) |
Apr 27 2012 | GHDX | GENOMIC HEALTH INC | LIVINGSTON RANDALL S | Director | Buy | M | 1.33 | 2,000 | 2,653 | 8,149 | 6.1 K to 8.1 K (+32.53 %) |